Edo, Dionisio, Jr. B.
HRN: 24-58-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2025
CEFTRIAXONE 1G (VIAL)
04/19/2025
04/21/2025
IV
2gm
OD
TC Psoas Abcess
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes